A transformative new health initiative has begun across the North East and North Cumbria as NHS leaders roll out...
Read MoreSeaport Therapeutics has officially dosed the first patient in its eagerly anticipated phase 2b BUOY-1 trial of GlyphAllo, a...
Read MoreIn a significant leap forward for the field of bacteriophage therapy, BiomX has published promising results from its phase...
Read MoreBiotech company Osivax has reached a significant milestone in its mission to transform influenza prevention, with new phase 2a...
Read MoreGermany has reached a landmark moment in the treatment of haemophilia B, as the first patient in the country...
Read MoreIn a significant stride towards improving prevention and treatment options for respiratory viruses, Pneumagen has unveiled the results of...
Read More